General Announcement::Glenmark Pharmaceuticals receives FDA Clearance of IND for GSP 304

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
08-Mar-2017 13:18:05
Status
New
Announcement Sub Title
Glenmark Pharmaceuticals receives FDA Clearance of IND for GSP 304
Announcement Reference
SG170308OTHRHWJH
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Executive Director
Description (Please provide a detailed description of the event in the box below)
As per Attachment

Attachments

Press_SGX.pdf
Total size =506K